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Holoprosencephaly (HPE) is a heterogeneous craniofacial and neural developmental anomaly characterized
in its most severe form by the failure of the forebrain to divide. In humans, HPE is associated with disruption
of Sonic hedgehog and Nodal signaling pathways, but the role of other signaling pathways has not yet been
determined. In this study, we analyzed mice which, due to the lack of the Bmp antagonist Noggin, exhibit
elevated Bmp signaling. Noggin2/2 mice exhibited a solitary median maxillary incisor that developed from
a single dental placode, early midfacial narrowing as well as abnormalities in the developing hyoid bone,
pituitary gland and vomeronasal organ. In Noggin2/2 mice, the expression domains of Shh, as well as the
Shh target genes Ptch1 and Gli1, were reduced in the frontonasal region at key stages of early facial devel-
opment. Using E10.5 facial cultures, we show that excessive BMP4 results in reduced Fgf8 and Ptch1
expression. These data suggest that increased Bmp signaling in Noggin2/2 mice results in downregulation
of the hedgehog pathway at a critical stage when the midline craniofacial structures are developing, which
leads to a phenotype consistent with a microform of HPE.
INTRODUCTION
Holoprosencephaly (HPE) is a developmental anomaly that can
present as a range of midline craniofacial and neural malfor-
mations. HPE is the most common developmental defect of
the forebrain and is characterized by the abnormal separation
of the telencephalon into left and right hemispheres and the
associated abnormal development of midline neural structures.
Alobar HPE is the most severe form of this developmental
defect, in which the prosencephalon does not separate along
both its medial–lateral and anterior–posterior axes which
result in a single uncleaved cerebral lobe, and the telencephalon
and diencephalon remain unsegmented. There is a spectrum of
clinical facial features including the presence of only one upper
central incisor tooth with an absent maxillary midline frenum,
cleft of the lip and or palate, nasal defects including single
nostril and nasal agenesis, central proboscis, hypotelorism and
cyclopia (1,2). When these features appear without defects in
the central nervous system, they are termed ‘microforms’.
HPE occurs in 1 in 7600 live births (3). However, the incidence
is much higher, 1 in 240, during early embryogenesis with most
embryos undergoing spontaneous abortion (4).
The etiology of HPE is heterogeneous with both genetic and
environmental factors. Environmental factors include poorly
controlled maternal diabetes, alcohol, vitamin A analogues
and alteration in cholesterol metabolism (5). Approximately
25% of HPE cases are syndromic; these syndromes include
Pallister–Hall, Rubinstein–Taybi and Smith–Lemli–Opitz.
In non-syndromic cases, 12 different chromosomal loci have
been implicated in HPE and mutations in 7 genes have been
found to cause HPE, and these are all members of the Hedge-
hog and Nodal signaling pathways. Genes with mutations
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known to cause HPE are SHH (HPE3), the Hedgehog receptor
Patched 1 (PTCH1) (HPE7), the transcription factors GLI2,
SIX3 (HPE2) and ZIC2 (HPE5), the Hedgehog regulator
GAS1, as well as Transforming growth factor interacting
factor (TGIF) and Teratocarcinoma-derived growth factor 1
(TDGF1/CRIPTO) (6–8).
Evidence from animal forebrain developmental studies and
the characterization of some of the genes causing HPE in
humans suggest that distinct mechanisms underlie the two
major classes of HPE (9). First, ‘classic’ HPE in which the
ventral telencephalon is most severely affected and where the
ventralizing effects of Shh signaling are disrupted. Second,
midline interhemispheric HPE or syntelencephaly in which
the dorsal telencephalon fails to split while the ventral telence-
phalon may be normal, and the dorsalizing effect of Bone mor-
phogenetic protein (Bmp) signaling is disrupted. Evidence for
the role of Bmp signaling in the pathogenesis of midline interhe-
mispheric HPE comes from the analysis of Bmpr1a2/2;
Bmpr1b2/2 compound mutant mice which exhibit a loss of all
dorsal midline cell types without affecting the specification of
cortical and ventral precursors in the telencephalon (10).
Bmps regulate many aspects of craniofacial morphogenesis
(11). Variations in Bmp signaling create morphological species-
specific diversification of the middle and upper face (12,13) and
Bmps together with retinoid acid specify the identity and regulate
the growth of the frontonasal mass and maxillary prominences
(14,15). Noggin is an extracellular Bmp antagonist which
binds, with picomolar affinity, to Bmp2, 4, 6 and 7 (16). This high-
binding affinity prevents Bmps from binding to their receptors
and subsequent signal transduction. Noggin null allele mice
exhibit elevated Bmp signaling which results in patterning and
growth defects of the neural tube and somites. In the appendicular
and axial skeleton cartilage is hyperplastic and there is a failure to
initiate joint formation (17–20).
In this study, we show that Noggin is expressed in the
midline of the developing upper face and that Noggin2/2
mouse embryos exhibit craniofacial abnormalities which
equate to a microform HPE. More specifically, the mutant
mice display a solitary median maxillary incisor, midfacial
narrowing and abnormalities in the developing hyoid bone,
pituitary gland and vomeronasal organ (VO). The Shh signal-
ing pathway regulates midface development and has also been
implicated in HPE. We found smaller expression domains of
Shh, and the Shh target genes Ptch1 and Gli1 in the frontona-
sal region of Noggin2/2 mice compared with their wild-type
(WT) littermates. Using bead implantation assays on E10.5
WT upper facial explants, we show that excessive BMP4
protein results in reduced expression of both Fgf8 and Ptch1.
Taken together, the present data suggest that disrupted Bmp
signaling can result in HPE by regulating the Fgf8-Shh
pathway and we put forward the Noggin2/2 mouse as a
model of microform HPE.
RESULTS
Noggin2/2 mice exhibit a narrowing of the frontonasal
process and a solitary median upper incisor
Noggin expression, revealed by LacZ staining, was analyzed in
mice at keys stages when the midline of the upper face is
patterned and undergoing major morphogenesis. At E9.5 and
E12.5, Noggin was detected in the midline of the developing
frontonasal process and in the developing nasal pits (Fig. 1).
E11.5 Noggin2/2 mouse embryos exhibited a shorter distance
between the lateral nasal processes compared with their WT lit-
termates. Furthermore, the morphology of the frontonasal mass
was abnormal, with Noggin mutant mice lacking the character-
istic invagination of the anterior/oral surface (Fig. 1). To quan-
tify these changes, we have carried out measurements on tissue
sections from WT and noggin null mice stained for Pax9
expression, a transcription factor used as a marker of the nasal
processes. In the absence of Noggin, the distance between
the nasal pits was found to be significantly reduced at E11.5
(P ¼ 0.02; WT ¼ 1.14 mm, n ¼ 12; Noggin2/2 0.86 mm,
n ¼ 9, non-paired t-test) (Fig. 1).
WT mice have two upper incisor teeth, each within separate
premaxillary bones. Noggin2/2 mice had a single upper incisor
Figure 1. Noggin is expressed in the developing face and Noggin2/2 mice
exhibit a narrow frontonasal process. (A–C) Whole-mount LacZ staining of
E9.5 and E12.5 mice. At E9.5, Noggin is expressed in the midline of the devel-
oping frontonasal process (arrowhead). Later Noggin expression is detected in
the midline of the frontonasal process as fine line which extends into the oral
cavity (arrow) and in the developing nasal pits (asterisks). (D and E) Schematic
diagram illustrates the upper face of an E11.5 mouse embryo. The red arrow indi-
cates the distance between the nasal pits.Noggin2/2mice have a shorter distance
between the nasal pits. (F and G) Localization of Pax9 in the developing upper
face of E11.5 WT andNoggin2/2mice. UsingPax9 as a marker of the lateral and
medial nasal processes, we were able to record a reduction in the distance
between the nasal pits in Noggin2/2 heads compared with their WT littermates.
fnp, frontonasal process; lnp, lateral nasal process; mnp, medial nasal process;
np, nasal pit. Scale bar: 1 mm. (F and G, same magnification). Error bars: stan-
dard deviation.
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located in the midline in a single premaxillary bone (Fig. 2). The
morphology of the incisor was analyzed in histological sections at
E16.5 (Fig. 2C and D). Instead of two separated tooth germs
positioned adjacently to the nasal cavity and separated by the
inter-premaxillary suture, Noggin2/2 mice had a single midline
incisor situated below the nasal septum.
In order to establish whether this tooth had developed from
a single primordium or from the fusion of two well-defined
primordia, we analyzed early tooth development in
Noggin2/2 mice and their WT littermates. During tooth devel-
opment, Shh is expressed in dental placodes, which are thick-
enings of the oral epithelium and represent the earliest stages
of tooth development. We performed whole-mount in situ
hybridization for Shh mRNA at E11.5 and E12.5 and found
that Noggin2/2 mice exhibit a single Shh expression domain
in the midline of the frontonasal process (9/10 mice)
(Fig. 2). This expression domain had not formed from two
placodes, as occurs in WT mice. In WT mice, two maxillary
incisor primordia were seen at E12.5; these had formed from
a continuous dental lamina. Also, we noted that the Shh
expression domain in the incisor placode was smaller in
Noggin2/2 mice compared with WT littermates (Fig. 2).
Consistent with previous reports, we found that the cranial
neural tube of most Noggin2/2 mice (18/22 E17.5 and
E18.5 mice) failed to close leaving the mutants with an
exencephalic phenotype (19).
Shh signal transduction is decreased in the oral region
in Noggin2/2 mice
As Shh expression domains in the incisor placode were smaller
in Noggin2/2 mice compared with the WT and because Shh
Figure 2. Noggin2/2 mice have a solitary median upper incisor tooth. (A and B) Premaxillary region of new born WT and Noggin2/2 mice stained with alcian
blue (cartilage) and alizarin red (bone). WT mice have two upper incisor teeth (A, arrowheads), whereas Noggin2/2 mice have only one (B, arrowhead). (C and
D) Hematoxylin and eosin stained frontal sections from E16.5 WT and Noggin2/2 heads confirming the presence of two upper incisors in WT mice and a single
upper incisor in Noggin2/2 mice (arrowheads). The developing upper incisor in Noggin2/2 mice has an abnormal thick stalk attachment to the oral epithelium
and abnormal epithelial convolutions (D). Associated with the dental epithelium is a condensed dental mesenchyme. (E–H) Shh whole-mount in situ hybrid-
ization of E11.5 and E12.5 WT and Noggin2/2 oral region. (E) In WT mice, at E11.5, Shh expression is seen in the two mandibular incisors (arrowheads) and in
the continuous maxillary dental lamina (arrow). (F) In Noggin2/2 mice, dental development is delayed in that Shh mRNA is not detected in the oral region.
(G and H) At E12.5, WT mice have two upper incisor primordia (G, arrowheads) and two lower incisor primordia which express Shh. Noggin2/2 exhibit
two lower primordia which express Shh but have only one centrally positioned incisor primordium which is smaller than its WT counterparts (F, arrowhead).
np, nasal pit; ns, nasal septum; t, tongue. Scale bars: 0.5 mm. Images on the left of the panel are the same magnification as the images on the right.
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signaling has been shown to developmentally regulate midfa-
cial width, we compared the expression of several genes
involved in the Shh pathway in the midline facial regions of
WT and Noggin2/2 mice during early embryogenesis (E11.5
and E12.5) (Fig. 3). In WT mice, Shh was expressed in the
oral epithelium and facial ectoderm, as well as the pharyngeal
endoderm and diencephalic epithelium. In Noggin2/2 mice,
Shh was absent from the oral epithelium (Fig. 3D). The trans-
membrane receptor Ptch1 and the transcription factor Gli1 are
both targets of Shh. Consistent with previous reports that there
is a gradient of Hh signaling activity across the craniofacial
region (21), we found that in WT mice the expression of
Ptch1 and Gli1 was strongest near to the expression domains
of Shh and that this mesenchymal expression reduced with
increasing distance from the epithelium (Fig. 3C–J). In
Noggin2/2 mice, the expression levels of Ptch1 and Gli1 in
the mesenchyme adjacent to the oral epithelium were
reduced, consistent with the reduction in Shh expression
(Fig. 3F, H, J).
As Bmp2, -4 and -7 are binding partners of Noggin and
because the Noggin null phenotype is caused by the deregula-
tion of Bmp signaling (17,22), we analyzed the expression of
Bmp2, -4 and -7 during early facial development. Noggin is
expressed in the epithelium of the developing frontonasal
mass (Fig. 1A–C) (23). At E10.5, Bmp2 was expressed in
the nasal epithelium, then at E12.5 in the pharyngeal
Figure 3. Decreased Shh signal transduction in the oral region of Noggin2/2 mice. (A–H) Sagittal sections through the midline region of WT and Noggin2/2
mice. (A–H) E11.5 (A and B) hematoxylin and eosin stained sections. (C–J) 35S-in situ hybridization for Shh signaling pathway members. (C and D) Shh is
expressed in the oral epithelium (C, arrowhead), pharyngeal endoderm and neuro epithelium of the diencephalon. In Noggin2/2 mutant mice, the expression of
Shh is missing from the oral epithelium (D, arrowhead). (E and G) Ptch1 and Gli1 are expressed in the oral epithelium and in the facial mesenchyme (arrow-
heads). They show a gradient of transcriptional activity across these regions away from the epithelium, the source of hedgehog ligand. (E–H) In Noggin2/2
embryos, there is a reduction in the expression of Ptch1 and Gli1 in facial region compared with WT littermates (arrowheads). (I and J) E12.5 frontal sections.
Ptch1 expression domain smaller in Noggin2/2 mice compared with WT littermates (arrowheads). fe, facial ectoderm; fnp, frontonasal process; mp, mandibular
process; ne, neural ectoderm; oe, oral epithelium; pe, pharyngeal endoderm. Scale bars: (A) 200 mm; (I) 500 mm. (A–H, same magnification) (I and J, same
magnification).
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endoderm and in the mandibular process. Bmp4 and Bmp7
were expressed in the facial, oral and mandibular epithelia
as well as in the mesenchyme of the frontonasal mass and
the first branchial arch (mandible) at both E10.5 and E12.5
(Supplementary Material, Fig. S1).
It has been reported that Bmp4 expression is more intense
and has an expanded domain in the first branchial arch of
Noggin2/2 mice compared with WT littermates (24). Using
in situ hybridization, we tested whether the expression of
Bmp4 and Bmp7 were changed in the midline of the develop-
ing face in Noggin2/2 mice. Similar to WT littermates, Bmp4
and Bmp7 were expressed in the epithelium and mesenchyme
of the frontonasal mass and in the first branchial arch. Levels
of intensity were comparable to those found in WT littermates
(Supplementary Material, Fig. S1).
BMP4 inhibits Fgf8 and Ptch1 in the developing midface
In the developing chick face, it has been shown that
increasing levels of Bmp leads to a downregulation of
Fgf8 and Shh (23). We postulated that increased Bmp sig-
naling could, via Fgf8, reduce Shh signaling in the develop-
ing frontonasal process and thereby result in the Noggin2/2
phenotype. Using bead assays, we tested the effects of
adding exogenous BMP4 to E10.5 mouse facial organ cul-
tures. BMP4 downregulated Fgf8 in the nasal pit [8/9
explants, compared with 2/9 with bovine serum albumin
(BSA)] (Fig. 4). Fgf8 and Shh are expressed in the facial
ectoderm; however, Shh signals to its receptor Ptch1 which
is located in the facial mesenchyme to regulate facial mor-
phogenesis. As ligand binding to Ptch1 initiates signal trans-
duction and as Ptch1 is also upregulated by the binding of
Hh, Ptch1 expression is regarded as a readout of Hh signal-
ing. We therefore investigated the effects of BMP4 on Ptch1
expression in the developing mouse frontonasal process and
found that BMP4 downregulated Ptch1 expression (9/11
explants, compared with 2/11 with BSA). Thus, in Noggin
null allele mice, increased Bmp activity may inhibit Fgf 8/
Shh-dependent facial development.
Normal palate formation despite abnormal early shelf
morphogenesis
Cleft lip and/or palate are part of the spectrum of features in
human HPE. We examined the developing lips and palate
of Noggin2/2 and WT mice from the initial stages of
Figure 4. BMP4 downregulates Fgf8 and Ptch1 in the developing mouse face. (A–D) WT mouse heads cultured overnight with beads impregnated with BMP4
or BSA. (A and B) E10.5 whole-mount in situ hybridization for Fgf8. Fgf8 is downregulated in the nasal pit in response to BMP4. (C and D) E11.5 whole-mount
in situ hybridization for Ptch1. Ptch1 is downregulated in mesenchyme underlying the nasal pit in response to BMP4 (arrow), but Ptch1 expression is maintained
in the contralateral side (C, arrowhead) and in response to BSA (negative control, D arrowheads). Nasal pits demarcated with red dotted lines. Asterisks indicate
bead locations. Scale bars 500 mm. (A and B, same magnification) (C and D, same magnification).
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development at E12.5 until after palatal shelf fusion is com-
plete at E16.5 and E18.5. Normally, the palatal shelves
develop as buds from maxillary processes and then start to
grow downwards between the tongue and the floor of the
mouth. The palatal shelves elevate rapidly between E14.0
and E14.5 to a position above the tongue, where after they
approximate in the midline and fuse. In Noggin2/2 mice,
the palatal shelves appeared morphologically normal at
E12.5; however at E13.5, they were thick and bulbous in
shape and had failed to grow down between the tongue and
floor of mouth instead remaining above the dorsum of the
tongue (Fig. 5). Noggin2/2 palatal shelves met in the
midline and fused normally so that by E16.5 a normal palate
had formed (20/21 mice) (Fig. 5G and H).
Figure 5. Palate and hyoid bone development in Noggin2/2 mice. (A–H) Hematoxylin and eosin stained frontal sections of WT heads and Noggin2/2 heads
E12.5–E16.5. In WT mice, the palatal shelf primordia bud from the maxillary processes (A), they extend into a position between the tongue and the floor of the
mouth, (C) then elevate to a position between the tongue dorsum and the nasal capsule (E) and fuse in the midline. (D) In contrast, the palatal shelves of
Noggin2/2 mice were in a position above the tongue, already at E13.5. (D and F) Also, the shape of the Noggin2/2 palatal shelves was not ‘finger-like’ but
more bulbous. (H) At E16.5, the palatal shelves of Noggin2/2 mice appeared normal having fused together. (I–L) Alcian blue and alizarin red staining of
hyoid bones from WT and Noggin2/2 mice. (I and J) At E16.5, the Noggin2/2 hyoid is bigger than its WT counterpart. In both WT and Noggin2/2 mice,
the body of the hyoid has started to mineralize (arrowheads). (K and L) At E18.5, the body of the Noggin2/2 hyoid bone is larger. It has four instead of
two cornua which are thicker, shorter and prematurely mineralized compared with their WT littermates. b, body of the hyoid bone; gc, greater cornua of
hyoid bone; m, upper molar tooth; mc, Meckel’s cartilage; nc, nasal cavity; np, nasal projection of the maxillary bone; ns, cartilage primordium of the nasal
septum; oc, oral cavity; t, tongue; vc, vomeronasal cartilage; ∗palatal shelves. Scale bars: (A) 500 mm, (I) 1 mm (A–H, same magnification) (I–L, same
magnification).
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It seems likely that this phenotype is, at least in part, sec-
ondary to abnormalities causing the mandible and tongue to
be held down so that the palatal shelves remain above the
tongue. Meckel’s cartilages in Noggin2/2 mice were greatly
enlarged holding the oral cavity open (Fig. 5). In addition,
there were developmental abnormalities in the hyoid bone.
The hyoid bone is a U-shaped bone positioned below the
mandible in the anterior triangle of the neck. It gives attach-
ment to muscles controlling the function of the tongue and
mandible. The hyoid comprises a body, two greater cornua
and two lesser cornua. It develops from cartilages from the
pharyngeal arches (PA), the body from both PA II and III,
the lesser cornua from PA II and the greater cornua from
PA III. We examined the hyoid bones by alizarin red (bone)
and alcian blue (cartilage) staining at E16.5, E17.5 and
E18.5. Already at E16.5, the mutant hyoid bones/cartilages
were much larger than in their WT littermates (Fig. 5I and
J). In WT E18.5 mice, the hyoid was composed of a body
and greater cornua with the lesser cornua developing later,
while the hyoid of Noggin2/2 mice was abnormal in size,
shape and number of cornua (Fig. 5K and L) (5/5 mice).
The body of the hyoid bone was enlarged greatly and its
shape changed with four instead of two cornua. These
cornua were shorter, wider and mineralized distally compared
with the cornua of WT littermates.
In WT mice, the palatal shelves develop in an oral cavity
that is expanding in all directions. As Noggin2/2 mice
exhibit a lack of midfacial transverse growth, the oral cavity
is narrow and this may allow the palatal shelves to touch
and fuse so that a palate could form. That said, 2 out of 31
Noggin2/2 mice exhibited facial clefts and 1 out of 21 mice
exhibited a cleft palate (data not shown).
The vomeronasal capsule is absent in Noggin2/2 mice
The VO (also known as Jacobson’s organ) is an auxiliary
olfactory sense organ situated adjacent to the cartilage of
the nasal septum, mainly used to detect pheromones.
The VO is a c-shaped structure surrounded by a cartilagi-
nous capsule which opens into the base of the nasal
cavity. The vomeronasal capsule is a structure distinct
from the nasal septum, which it neighbors. Histological
analysis of the frontal section of Noggin2/2 E16.5 heads
revealed that the epithelial section of the VO appeared
normal (Fig. 6). However, the vomeronasal capsule was
missing in the Noggin2/2 mutants and the mesenchyme
around the VO was reduced in size (in all animals
examined).
Figure 6. Abnormalities of the VO in Noggin2/2 mice. (A–F) E16.5 hematoxylin and eosin stained frontal sections of WT and Noggin2/2 heads showing the
developing nasal septum and VO. The VO is similar in WT and Noggin2/2 mice (arrowheads), however the vomeronasal cartilage (vc) which cups the WT VO
is missing in Noggin2/2 mice, the mesenchyme surrounding the VO is reduced as is the developing nasal projection of the maxillary bone. The cartilage of the
nasal septum is greatly enlarged in Noggin2/2 mice. np, nasal projection of the maxillary bone; ns; cartilage primordium of the nasal septum; vc, vomeronasal
cartilage. Scale bar: (A) 200 mm (A–F, same magnification).
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Pituitary gland abnormalities in Noggin2/2 mice
The developing pituitary gland was analyzed in sagittal and
coronal sections at E13.5, E14.5 and E16.5 (Supplementary
Material, Fig. S2, data not shown). The most notable feature
in Noggin2/2 mice was that the developing pituitary was
smaller when compared with WT mice, especially the pars
anterior. The pars anterior (pars distalis) ultimately produces
the most of the pituitary hormones. Other defects that have
previously been reported in Noggin2/2 mice include a
rostral displacement of Rathke’s pouch and the induction of
secondary pituitary tissue (25).
DISCUSSION
Noggin null allele mice exhibit several craniofacial abnormal-
ities including a narrowed frontonasal process, a solitary
median maxillary incisor and defects in the hyoid bone, VO
and pituitary gland. All these Noggin-related facial anomalies
are characteristic of a microform of HPE and are associated
with reduced expression of hedgehog target genes. Our find-
ings are consistent with the hypothesis that Bmps have a
role in midline patterning and the regulation of midface
width by inhibiting Shh signaling.
Solitary median upper incisor
WT mice have two upper incisors. We found that Noggin2/2
mice have a solitary median upper incisor (100% penetrant),
which develops from single expression domain in the
midline of a single premaxillary bone. We cannot rule out
that the single Shh expression domain is a consequence of a
lack midline tissue intervening between two anlagen which
have subsequently fused together, although this is relatively
unlikely as the centrally located Shh domain in the
Noggin2/2 mice is smaller than the individual domain of
WT upper incisors. Alterations in the number of teeth can
be caused by irregularities in the tooth initiation process
(26). In Noggin2/2 mice, the single incisor is part of a HPE
midfacial phenotype where the lack of tissue in the midline
and a patterning defect are responsible for the tooth pheno-
type. Overactivation of Noggin in the oral epithelium using
transgenic tools (K14 promoter) does not result in a change
in the number of incisors. However, the morphology and struc-
ture of the K14-Noggin incisors are altered: incisors are large
with abnormalities in enamel and dentine formation. In
addition, all mandibular and maxillary third molars are lost
due to developmental arrest at the early bud stage (27).
Humans normally have two deciduous and two permanent
central incisors and the development of a solitary median
maxillary central incisor (SMMCI) in the primary and/or
secondary dentition is rare. SMMCI can occur as part of a
holoprosencephalic phenotype, in association with abnormal-
ities not related to HPE or as an apparently isolated finding.
Missense mutations in SHH have been reported in patients
with SMMCI that do not have other features of HPE
(28,29). The I111F mutation has been found in eight
members of the same family and it has been suggested that
this mutation may be specific for SMMCI as it has not been
found in either HPE patients or in a normal population (28).
Hypopituitarism
Hypopituitarism due to pituitary hypoplasia has been
described in patients with SMMCI together with other
HPE-like features and has been reported in patients with loss
of function mutations in the HH signaling transcription
factor GLI2 (30,31). In zebrafish, it has been shown that
Gli1 and Gli2 regulate Hh signaling to induce and pattern
the developing adenohypophysis (32). And in mice, 50% of
Gli22/2 mutants and 100% of Gli22/2;Gli12/2 mutants fail
to develop a pituitary gland (33). Whether Bmp and Hh signal-
ing interact during pituitary development is not known. In
Noggin2/2 mice, the pituitary abnormalities appear to be
due to an expanded domain of Bmp4 activity that results in
Fgf10 repression and rostral shift of the Bmp4 and Shh
boundary (25).
Midfacial width is regulated by Noggin
Several studies have analyzed the role of Bmps and other
growth factors in the control of facial proximal/distal out-
growth, but very few have addressed what controls facial
width. Here we show that Bmp, by modulating Shh signaling,
plays a fundamental role in regulating facial width. Although
the facial features of Noggin2/2 mice have not been pre-
viously reported, there is evidence that Bmps control facial
patterning and growth and that alteration of Bmp signaling
can lead to HPE. For instance, compound mouse mutants for
Chordin and Noggin (34,35) or chick embryos that have had
BMP4-soaked beads implanted into their forebrains (36)
exhibit holoprosencephalic facial features including cyclopia,
a central proboscis and orofacial clefting. With regard to the
proximal/distal outgrowth of the facial processes, Noggin-
soaked beads implanted into the developing chick face at
different developmental stages results in decreased cell
proliferation and subsequently decreased outgrowth, smaller
frontonasal and maxillary processes and deletion of the maxil-
lary and palatine bones (14,15,23).
We show that in Noggin2/2 mice, Shh and the Shh target
genes Ptch1 and Gli1 are misexpressed at E11.5 and E12.5
in the developing face. This suggests that disrupted Bmp
signaling in Noggin2/2 mice results in downregulation of
the hedgehog pathway at the critical time when the midline
craniofacial structures are developing. This is supported by
experiments in the developing chick that demonstrate that
excessive exogenous BMP2 (micro bead implantation) down-
regulates Shh expression (23), and transient loss of SHH sig-
naling by either excision of the frontonasal epithelium or by
the introduction of Shh neutralizing antibodies inhibits
growth of the facial primordia and results in a narrowing of
the mid and upper face and subsequent hypotelorism (37).
Also, mice lacking the transmembrane protein Cdo, which
positively regulates Shh signaling, exhibit HPE with a
midface hypoplasia and hypotelorism (38).
Disruption in Shh signal transduction by exposing chick
embryos, at Hamilton Hamburger stages 15 and 17, to the
Smoothened inhibitor cyclopamine, results in a continuum of
HPE-related defects including hypotelorism (39). The time
when Shh signaling, and presumably Bmp signaling, is
blocked is critical. Early blockade of Shh (before the division
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of the eye field into two) (stage 4) causes cyclopia, Shh block-
age later (stages 15 and 17) results hypotelorism, midfacial
hypoplasia and orofacial clefting, while blockage later in
development has no effect (39). Conversely, excessive SHH
in the embryonic face leads to increased proliferation in the
frontonasal process, increased width of mid and upper facial
processes and consequently hypertelorism (37). When consid-
ering facial development, it is important to differentiate
between early abnormal Shh signaling from the developing
brain and signaling later from the developing facial structures.
In this study, we show that exogenous BMP4 inhibits Fgf8
and Ptch1 in the developing mouse frontonasal process. Fgf8
is a key regulator of facial development which is known to
regulate Shh signaling in several embryonic locations, includ-
ing the limb and genital tubercle. Blocking Fgf signaling in the
developing chick face results in a narrowing of the upper face,
approximation of the maxillary processes and a coalescence of
the nasal pits into a single central pit (40). There is good evi-
dence that during very early chick facial development Bmp
signaling acts to restrict Fgf8 expression (41). Equally, block-
ing endogenous Bmp signaling in the developing chick fronto-
nasal prominence by overexpressing Noggin results in an
expansion of the Fgf8 domain (40). Taken together, the down-
regulation of Fgf8 and Hedgehog signaling by excessive Bmp
signaling provides a mechanism underlying the HPE in the
Noggin null allele mouse.
Mutations in SHH/Shh, as well as mutations in several
hedgehog signaling pathway members, result in HPE in both
humans and mice. Human and mouse mutations of GLI2/
Gli2 have been shown to cause HPE-like phenotypes, includ-
ing midfacial hypoplasia with a single maxillary incisor
(31,42). A SHH missense mutation has been associated with
HPE and shown to cause defective binding to the HH regulator
GAS1 (43). Indeed, mutations in GAS1 alone or in addition to
mutations in SHH can result in HPE in humans (8). Similar
to Noggin2/2 mutants, 40–50% of Gas12/2 mice exhibit
several features consistent with a microform of HPE including
a single maxillary incisor, a narrow frontonasal process and
abnormalities in the pituitary, palate and VO (21). The
Gas12/2 phenotype appears to be due to a reduction in Shh
signaling as loss of a single allele of Shh in the Gas12/2 back-
ground worsened the craniofacial phenotype and Gas12/2
mice exhibit a reduced Ptch1 expression domain in the devel-
oping frontonasal process (21,44).
Noggin2/2 mice have a narrow facial width and malformed
neural crest cell derivatives, namely the upper incisors, pre-
maxillary bones, nasal septum and the palate. There is
evidence that Bmp signaling is important in neural crest induc-
tion, delamination and migration and it has been suggested
that elevated Bmp signaling disrupts the development of post-
migratory, differentiating skeletal neural crest cells (18,24,34).
Thus, overexpression of Noggin in the second branchial arch
(Hoxa2) results in reduced numbers of neural crest cells and
consequently hypomorphic skeletal and neural elements (45).
Also, Noggin may protect neural crest cells from apoptosis
induced directly by elevated Bmp signaling, and indirectly
by maintaining Shh signaling as Noggin and also Chordin
promote the rostral expression of Shh (34). Noggin and
Chordin are Bmp antagonists that have similar biochemical
activity and expression domains and may well compensate
functionally for each other. Compound mutant mice for
Noggin and Chordin display a variety of HPE craniofacial
defects (24,34,35). Consistent with our data, disruption of
Bmp and Follistatin signaling in the chick results in a holopro-
sencephalic phenotype through a mechanism which involves
modulating midline Shh signaling (46).
Despite multiple regulators controlling the Bmp pathway,
disruption of Noggin alone is sufficient to result in the midfa-
cial phenotype described in this paper. In conclusion, we
demonstrate the importance of Noggin in the correct pattern-
ing of the face and in the etiology of HPE.
MATERIALS AND METHODS
Mice
The generation, breeding and genotyping of the Noggin
mutant mice used in this study have been described previously
(17,22). The initial inactivation of the Noggin gene was done
in an inbred 129SvJ genetic background. Heterozygote males
have been serially backcrossed with CD1 females for at least
10 generations. NogginLacZ reporter mice were backcrossed
to C57BL/6 and used as heterozygotes.
Skeletal and LacZ staining
Alcian blue/alizarin red and LacZ staining were performed
according to Rice et al. (2010) and Zouvelou et al. (2009)
(47,48).
Organ culture
E10.5 and E11.5 WT mouse heads were dissected and placed
on Nuclepore filters in a Trowell-type organ culture system as
described previously (49). Affi-gel agarose beads (Biorad)
were incubated with recombinant human BMP4 (100 ng/ml,
R&D Systems) or BSA at 378C for 1 h and stored at 48C
before being placed on the explants. Bead assays were
cultured overnight.
Preparation of probes and in situ hybridization
35S in situ hybridization on paraffin sections was performed as
previously described (50). Both bright and dark field images
were taken of hybridized sections. Silver grains were selected
from the dark field images, colored red and then superimposed
onto the identical bright field image using Adobe Photoshop
6.0 software. Whole-mount in situ hybridization was per-
formed using digoxigenin-UTP-labelled riboprobes as pre-
viously described (51). The preparation of the Bmp, Fgf8,
Gli1, Pax9, Ptch1 and Shh RNA probes has been described
previously (52–54).
Statistical analysis
An independent samples t-test was used for the statistical
analysis of normally distributed samples. A P-value of
,0.05 was considered statistically significant. SPSS 15.0
was used for the statistical analysis of the data.
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